BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 83 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,311,953 | +7.8% | 91,045 | +22.8% | 0.00% | 0.0% |
| Q2 2023 | $1,217,161 | +1.4% | 74,127 | +3.4% | 0.00% | 0.0% |
| Q1 2023 | $1,200,458 | +56.9% | 71,712 | +44.5% | 0.00% | 0.0% |
| Q4 2022 | $765,118 | +10.7% | 49,632 | +7.2% | 0.00% | 0.0% |
| Q3 2022 | $691,000 | -3.2% | 46,290 | +7.5% | 0.00% | 0.0% |
| Q2 2022 | $714,000 | +121.7% | 43,075 | +76.2% | 0.00% | +100.0% |
| Q1 2022 | $322,000 | -48.1% | 24,450 | +0.2% | 0.00% | 0.0% |
| Q4 2021 | $621,000 | -10.9% | 24,397 | -5.2% | 0.00% | 0.0% |
| Q3 2021 | $697,000 | +33.0% | 25,745 | +42.4% | 0.00% | 0.0% |
| Q2 2021 | $524,000 | +6.7% | 18,077 | -3.2% | 0.00% | 0.0% |
| Q1 2021 | $491,000 | +0.8% | 18,670 | +9.7% | 0.00% | 0.0% |
| Q4 2020 | $487,000 | +1.9% | 17,012 | -15.0% | 0.00% | 0.0% |
| Q3 2020 | $478,000 | +350.9% | 20,023 | +294.8% | 0.00% | – |
| Q2 2020 | $106,000 | +17.8% | 5,072 | +1.4% | 0.00% | – |
| Q1 2020 | $90,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
| Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
| 1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
| EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
| Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
| Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
| Matisse Capital | 51,296 | $739,175 | 0.52% |
| Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
| Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |